Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells.

Matrix Biology : Journal of the International Society for Matrix Biology
Ilya SerebriiskiiEdna Cukierman

Abstract

Recent studies have emphasized the importance of cellular microenvironment in modulating cell growth and signaling. In vitro, collagen matrices, Matrigel, and other synthetic support systems have been used to simulate in vivo microenvironments, and epithelial cells grown in these matrices manifest significant differences in proliferation, differentiation, response to drugs, and other parameters. However, these substrates do not closely resemble the mesenchymal microenvironment that is typically associated with advanced carcinomas in vivo, which is produced to a large extent by fibroblasts. In this study, we have evaluated the ability of a fibroblast-derived three-dimensional matrix to regulate the growth of a panel of 11 human tumor epithelial cell lines. Although proliferative and morphological responses to three-dimensional cues segregated independently, general responsiveness to the matrix correlated with the ability of matrix to influence drug responses. Fibroblast-derived three-dimensional matrix increased beta1-integrin-dependent survival of a subset of human cancer cell lines during taxol treatment, while it sensitized or minimally influenced survival of other cells. beta1-integrin-dependent changes in cell resistance to...Continue Reading

References

Jun 5, 1991·Journal of the National Cancer Institute·A MonksA Vaigro-Wolff
Jan 28, 1986·Biochemistry·H K KleinmanG R Martin
Mar 1, 1996·Nature Medicine·G S Wu, W S El-Diery
Jul 25, 2000·Molecular Medicine Today·C C ParkM H Barcellos-Hoff
Nov 27, 2001·Science·E CukiermanK M Yamada
Sep 17, 2002·Current Opinion in Cell Biology·Edna CukiermanKenneth M Yamada
Dec 21, 2002·Differentiation; Research in Biological Diversity·Mina J BissellOle W Petersen
Mar 29, 2003·Physiological Reviews·Marc Mareel, Ancy Leroy
May 2, 2003·Nature Reviews. Cancer·Peter Friedl, Katarina Wolf
Sep 10, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Patrice J Morin
Jan 23, 2004·Nature Reviews. Cancer·John Condeelis, Jeffrey E Segall
Mar 24, 2004·Current Opinion in Cell Biology·Peter Friedl
Apr 28, 2004·Current Opinion in Genetics & Development·Nastaran Zahir, Valerie M Weaver
Sep 7, 2004·The International Journal of Developmental Biology·Alexis DesmoulièreGiulio Gabbiani
Oct 21, 2004·The Journal of Pathology·Christine Chaponnier, Giulio Gabbiani
Nov 19, 2004·Nature·Neil A BhowmickHarold L Moses
Apr 13, 2005·Journal of Biosciences·Ana M Soto, Carlos Sonnenschein
Jun 25, 2005·Seminars in Cancer Biology·Jong Bin Kim
Jun 25, 2005·Seminars in Cancer Biology·Hynda K Kleinman, George R Martin
Aug 23, 2005·Experimental Cell Research·Paulo FerreiraGianpaolo Suriano
Sep 1, 2005·The Journal of Cell Biology·Roumen PankovKenneth M Yamada
Sep 20, 2005·Cancer Cell·Matthew J PaszekValerie M Weaver
Oct 14, 2005·BMC Medical Research Methodology·Joseph Beyene, Rahim Moineddin
Nov 1, 2005·Experimental Cell Research·Frederick GrinnellHongmei Jiang
Nov 24, 2005·Experimental Eye Research·Marcelo V NettoSteven E Wilson
Dec 24, 2005·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Takumi AkashiMasaki Yanagishita
Feb 24, 2006·Nature Reviews. Molecular Cell Biology·Jean Paul Thiery, Jonathan P Sleeman
Feb 24, 2006·Nature Reviews. Molecular Cell Biology·Linda G Griffith, Melody A Swartz
Nov 14, 2006·The Journal of Pharmacology and Experimental Therapeutics·Réna G DeschesnesEric Petitclerc
Mar 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Sangmyung RheeFrederick Grinnell
Jul 4, 2007·The Journal of Cell Biology·Gilles GadeaPierre Roux
Aug 28, 2007·Cell·Kenneth M Yamada, Edna Cukierman
Sep 4, 2007·Nature Methods·Claudia FischbachDavid J Mooney
Oct 16, 2007·Cell Biology International·Ralica DamianovaRoumen Pankov

❮ Previous
Next ❯

Citations

Feb 13, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·G Chometon, V Jendrossek
Nov 19, 2011·Journal of Laboratory Automation·David D NolteKwan Jeong
Jun 26, 2010·Integrative Biology : Quantitative Biosciences From Nano to Macro·Maret BauerAndreas Friedl
Feb 10, 2009·Tissue Engineering. Part C, Methods·Jed JohnsonJohn J Lannutti
Sep 8, 2011·Journal of Biomedical Optics·David D NolteKwan Jeong
Jul 20, 2012·Chemotherapy Research and Practice·Georges SaidHassan El Btaouri
Aug 17, 2010·Cancer Cell International·Emilie Millerot-SerrurotPierre Jeannesson
Feb 26, 2014·Stem Cell Research & Therapy·Monica MoyaSteven C George
Sep 6, 2012·International Journal of Molecular Sciences·Magali CastellsBettina Couderc
Mar 19, 2014·Life Sciences·Kevin DzoboM Iqbal Parker
Apr 18, 2014·Nature Reviews. Cancer·James R W ConwayPaul Timpson
Dec 4, 2013·Advanced Drug Delivery Reviews·Maria HåkansonMirren Charnley
Aug 15, 2014·Biotechnology Advances·Xian XuXinqiao Jia
Apr 19, 2011·Journal of Cell Communication and Signaling·Agata NygaMarilena Loizidou
Oct 14, 2010·Cancer Research·Mahendra K SinghErica A Golemis
Dec 3, 2014·Advanced Drug Delivery Reviews·Anna V Taubenberger
Jun 28, 2014·Advanced Drug Delivery Reviews·Daniela LoessnerJudith Ann Clements
May 13, 2014·Advanced Drug Delivery Reviews·Stuart J EllemGail P Risbridger
Mar 27, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Harm HogenEsch, Alexander Yu Nikitin
Mar 1, 2011·Mathematical Biosciences·A Groh, M Wagner
May 11, 2010·Seminars in Cancer Biology·Edna Cukierman, Daniel E Bassi
Feb 27, 2014·Analytical Chemistry·Zeynep Dereli-KorkutSihong Wang
Jan 27, 2015·Biochemical and Biophysical Research Communications·Hong-Ju WangTakashi Ikejima
Oct 7, 2015·Methods : a Companion to Methods in Enzymology·Marta TelloJacky G Goetz
Apr 27, 2010·Biochemical Pharmacology·Edna Cukierman, David R Khan
May 3, 2016·Trends in Cancer·Lindsey A BakerDavid A Tuveson
Jul 30, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kathleen A FitzgeraldCaitriona M O' Driscoll
Apr 4, 2015·Tissue Engineering. Part C, Methods·Manuel BerningPetra Boukamp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Basement Membranes

Basement membranes are thin, specialized extracellular matrices surrounding most tissues in all metazoans. Here is the latest research on basement membranes.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis